Medical Oncology
Prof Fiona Thistlethwaite
6 months
Visiting Residency
Fluent in English. Proficiency in International English Language Testing System (IELTS) exam by the time of commencing position is required.
GMC registration prior to commencing position is required.
Programme description
The Christie’s Experimental Cancer Medicine Trials (ECMT) Team has a broad portfolio of over 20 currently recruiting Phase I and non-randomised Phase II trials with a focus on first-in-human, first-in-combination, biomarker and regulatory clinical pharmacology studies. The ECMT Clinical Fellows have wide-ranging opportunities to gain experience in clinical and translational research projects, clinical trials education through the Masters Programme in Experimental Cancer Medicine, as well as experience in the clinical management of patients on early phase clinical trials. Prof Fiona Thistlethwaite leads the Immune-oncology (IO) programme within ECMT. The field of IO has seen enormous expansion in recent years with the rapid develop of checkpoint inhibitors, now reaching into mainstream oncology. An ECMT IO Clinical Fellowship is an excellent opportunity to obtain clinical experience of managing patients enrolled into Phase I clinical trials across a range of tumour types being treated with novel immunotherapies and identifying and managing related toxicities. There is also the opportunity to become involved in and develop translational research projects within this exciting field.
